Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Shares Issued (2016 - 2025)

Abeona Therapeutics has reported Shares Issued over the past 12 years, most recently at $3.6 million for Q4 2025.

  • Quarterly results put Shares Issued at $3.6 million for Q4 2025, down 34.7% from a year ago — trailing twelve months through Dec 2025 was $26.4 million (up 70.68% YoY), and the annual figure for FY2025 was $17.3 million, up 11.79%.
  • Shares Issued for Q4 2025 was $3.6 million at Abeona Therapeutics, down from $10.5 million in the prior quarter.
  • Over the last five years, Shares Issued for ABEO hit a ceiling of $63.7 million in Q2 2024 and a floor of -$60.2 million in Q3 2024.
  • Median Shares Issued over the past 5 years was $6.0 million (2024), compared with a mean of $5.8 million.
  • Biggest five-year swings in Shares Issued: soared 360900.0% in 2021 and later crashed 467.98% in 2024.
  • Abeona Therapeutics' Shares Issued stood at $7.2 million in 2021, then surged by 293.5% to $28.4 million in 2022, then tumbled by 130.17% to -$8.6 million in 2023, then surged by 164.31% to $5.5 million in 2024, then tumbled by 34.7% to $3.6 million in 2025.
  • The last three reported values for Shares Issued were $3.6 million (Q4 2025), $10.5 million (Q2 2025), and $6.8 million (Q1 2025) per Business Quant data.